Skip to main content

Systemic sclerosis current therapy: - early dcSSc: MMF, CTX, RTX, TCZ - rapidly progressive dcSSc - ?Stem cell transpl?

Social Author Name
Dr. John Cush
Tweet Content
Systemic sclerosis current therapy: - early dcSSc: MMF, CTX, RTX, TCZ - rapidly progressive dcSSc - ?Stem cell transpl? - SSc-ILD: MMF>CTX, possibly nintedanib, perfinidone - Raynauds w/ digital ulcers: CA channel block, PDE5 inhib, iloprost, Bosentan https://t.co/z4OzFklrcl https://t.co/bM01inV2QY

Long-Term Benefit of Rituximab in Systemic Sclerosis A small cohort trial of rituximab (RTX) in 29 systemic sclerosis

Social Author Name
Dr. John Cush
Tweet Content
Long-Term Benefit of Rituximab in Systemic Sclerosis A small cohort trial of rituximab (RTX) in 29 systemic sclerosis patients showed significantly improved skin sclerosis and lung function after a follow-up of 96 weeks. https://t.co/qrtv9eK1Oz https://t.co/GdOyaCIPUA

Serum beta-2 microglobulin (B2M) in 100 #SLE pts - strong correlations betw B2M & 24 hr urinary protein, BUN, creati

Social Author Name
Dr. John Cush
Tweet Content
Serum beta-2 microglobulin (B2M) in 100 #SLE pts - strong correlations betw B2M & 24 hr urinary protein, BUN, creatinine, disease activity, & damage score (p < 0.001), & negatively correlated with GFR, C3, C4 (p < 0.001). B2M predicted lupus LN https://t.co/wXCs0WlIYv https://t.co/vZPWtnqIta

Metanalysis of 3 RCTs &amp; 19 observational studies, showed hematopoietic stem cell transplantation . (HSCT) significan

Social Author Name
Dr. John Cush
Tweet Content
Metanalysis of 3 RCTs & 19 observational studies, showed hematopoietic stem cell transplantation . (HSCT) significantly improved skin thickness and lung function. While HSCT had more deaths than IV CTX, HSCT had higher 2 yr survival rate https://t.co/FMWFfmYPod https://t.co/SFjlj1yV0x

Metanalysis shows Takayasu's arteritis pts are at higher risk of adverse pregnancy outcomes. (27 studies, 825 pregs) sh

Social Author Name
Dr. John Cush
Tweet Content
Metanalysis shows Takayasu's arteritis pts are at higher risk of adverse pregnancy outcomes. (27 studies, 825 pregs) showed more miscarriage (16%), hypertension (37%) and pre-eclampsia (14%) in TA patients (p < 0.01) https://t.co/stVx5jvPsj https://t.co/LaftdsHmSz

Does Methotrexate Work in Alopecia Universalis? Alopecia areata totalis (AT) and universalis (AU) are the most severe a

Social Author Name
Dr. John Cush
Tweet Content
Does Methotrexate Work in Alopecia Universalis? Alopecia areata totalis (AT) and universalis (AU) are the most severe and difficult to treat forms of alopecia areata (AA). https://t.co/x8EjMekMBJ https://t.co/ntejSJcG5M

CDC says EVERYONE should be tested for Hepatitis B al least once, w/ 3 lab - HBsAg, &amp; Abs to hepatitis B surface Ag

Social Author Name
Dr. John Cush
Tweet Content
CDC says EVERYONE should be tested for Hepatitis B al least once, w/ 3 lab - HBsAg, & Abs to hepatitis B surface Ag (anti-HBs), hep B core Ag (anti-HBc). At increased risk for HBV - persons in jail, +Hx of STDs, multiple sex partners or Hx of hepatitis C https://t.co/DRzAuhVJSJ https://t.co/9ma0I61xeD

Population study from Japan shows that Aging is an independent contributor for seronegative RA in patients who are femal

Social Author Name
Dr. John Cush
Tweet Content
Population study from Japan shows that Aging is an independent contributor for seronegative RA in patients who are female, have a nonsmoking history, and a BMI < 25. https://t.co/WWRGczmc4K https://t.co/ZHRIHlxDIK

1215 pts w/ refractory SJS/TEN (not responding to pulse steroids x 3d) compared subsequent plasmapheresis- vs IVIG treat

Social Author Name
Dr. John Cush
Tweet Content
1215 pts w/ refractory SJS/TEN (not responding to pulse steroids x 3d) compared subsequent plasmapheresis- vs IVIG treated patietns and shows similar mortality rates(18.3% vs 19.5%), but apheresis had more stays (45 vs 32 d) & cost ($34k vs $23k) https://t.co/QTnbPzf6Jd https://t.co/EgI2ueIhdz

Registration is still open! Join us at RheumNow Live on 3/18 and 3/19. We have a great agenda lined up including a pan

Social Author Name
Dr. John Cush
Tweet Content
Registration is still open! Join us at RheumNow Live on 3/18 and 3/19. We have a great agenda lined up including a panel on Rheumatoid Arthritis: Revolutionary Advances in Therapy. https://t.co/duAfKSDi1O https://t.co/JkbHa6b2Fg
Subscribe to
×